Seeing Is Believing
with an average price target of $2.86. This is a potential upside of $2.86 (0%) from yesterday's end of day stock price of $0.
Genomic Health's activity chart (see below) currently has 49 price targets and 25 ratings on display.
Analysts average stock forecasts to be materialized ratio is 73.39% with an average time for these price targets to be met of 148 days.
Most recent stock forecast was given by MARK MASSARO from BTIG on 30-Jul-2019. First documented stock forecast 31-May-2013.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 30-Jul-2019
$72
$8.56 (13.49%)
$77
6 years 6 months 18 days ago
(30-Jul-2019)
4/7 (57.14%)
$-2 (-2.70%)
284
Hold Since 30-Jul-2019
$69
6 years 6 months 18 days ago
(30-Jul-2019)
1/3 (33.33%)
$9.97 (16.89%)
81
Sell Since 02-Sep-2015
$72
$8.56 (13.49%)
$38
6 years 6 months 18 days ago
(30-Jul-2019)
2/3 (66.67%)
$-2 (-2.70%)
13
Hold Since 29-Jul-2019
$72
$8.56 (13.49%)
$25
6 years 6 months 19 days ago
(29-Jul-2019)
1/2 (50%)
$-1.07 (-1.46%)
7
Buy Since 20-Jun-2019
$72
$8.56 (13.49%)
$72
6 years 7 months 28 days ago
(20-Jun-2019)
4/5 (80%)
$16.88 (30.62%)
99
What is GHDX (Genomic Health) average time for price targets to be met?
Which analyst has the current highest performing score on GHDX (Genomic Health) with a proven track record?
Which analyst has the current lower performing score on GHDX (Genomic Health) with a proven track record?
Which analyst has the most public recommendations on GHDX (Genomic Health)?
Which analyst is the currently most bullish on GHDX (Genomic Health)?
Which analyst is the currently most reserved on GHDX (Genomic Health)?